The role of alcohol consumption in regulating circulating levels of adiponectin: A prospective cohort study

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 7, 2015, Pages 2763-2768

  Bell, Steven ^a   Britton, Annie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALCOHOL;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DRINKING BEHAVIOR; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEX; SMOKING HABIT; SOCIAL STATUS; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; UNITED KINGDOM;

ADIPONECTIN; ADULT; ALCOHOL DRINKING; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ETHANOL; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED;

EID: 84953855588     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1845     Document Type: Article

References (38)

1. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123-2132.
2. Beulens JWJ, Rimm EB, Hu FB, Hendriks HFJ, Mukamal KJ. Alcohol consumption, mediating biomarkers, and risk of type 2 diabetes among middle-aged women. Diabetes Care. 2008;31(10): 2050-2055.
3. Thamer C, Haap M, Fritsche A, Haering H, Stumvoll M. Relationship between moderate alcohol consumption and adiponectin and insulin sensitivity in a large heterogeneous population. Diabetes Care. 2004;27(5):1240-1240.
4. Englund Ögge L, Brohall G, Behre CJ, Schmidt C, Fagerberg B. Alcohol consumption in relation to metabolic regulation, inflammation, and adiponectin in 64-year-old Caucasian women: a population-based study with a focus on impaired glucose regulation. Diabetes Care. 2006;29(4):908-913.
5. Imhof A, Plamper I, Maier S, Trischler G, Koenig W. Effect of drinking on adiponectin in healthy men and women: a randomized intervention study of water, ethanol, red wine, and beer with or without alcohol. Diabetes Care. 2009;32(6):1101-1103.
6. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
7. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009; 302(2):179-188.
8. Lai H, Lin N, Xing Z, Weng H, Zhang H. Association between the level of circulating adiponectin and prediabetes: a meta-analysis. J Diabetes Investig. Published online ahead of print March 31, 2015. doi: 10. 1111/jdi. 12321.
9. Kanhai DA, Kranendonk ME, Uiterwaal CSPM, van der Graaf Y, Kappelle LJ, Visseren FLJ. Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies. Obes Rev. 2013;14(7):555-567.
10. Dalamaga M, Diakopoulos KN, Mantzoros CS. The role of adiponectin in cancer: a review of current evidence. Endocr Rev. 2012; 33(4):547-594.
11. Leo R, Di Lorenzo G, Tesauro M, et al. Decreased plasma adiponectin concentration in major depression. Neurosci Lett. 2006;407(3): 211-213.
12. Joosten MM, Chiuve SE, Mukamal KJ, Hu FB, Hendriks HFJ, Rimm EB. Changes in alcohol consumption and subsequent risk of type 2 diabetes in men. Diabetes. 2011;60(1):74-79.
13. Britton A, Ben-Shlomo Y, Benzeval M, Kuh D, Bell S. Life course trajectories of alcohol consumption in the United Kingdom using longitudinal data from nine cohort studies. BMCMed. 2015;13:47.
14. Tabák AG, Carstensen M, Witte DR, et al. Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study. Diabetes Care. 2012;35(12):2540-2547.
15. Marmot M, Brunner E. Cohort Profile: The Whitehall II study. Int J Epidemiol. 2005;34(2):251-256.
16. Carstensen M, Herder C, Kivimäki M, et al. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II Prospective Cohort Study. Diabetes. 2010;59(5):1222-1227.
17. Chikirzhs T, Fillmore K, Stockwell T. A healthy dose of skepticism: four good reasons to think again about protective effects of alcohol on coronary heart disease. Drug Alcohol Rev. 2009;28(4):441-444.
18. Rehm J, Irving H, Ye Y, Kerr WC, Bond J, Greenfield TK. Are lifetime abstainers the best control group in alcohol epidemiology? On the stability and validity of reported lifetime abstention. Am J Epidemiol. 2008;168(8):866-871.
19. KotaniK,HazamaA,HagimotoA,et al. Adiponectinandsmokingstatus: a systematic review. J Atheroscler Thromb. 2012;19(9):787-794.
20. Schisterman EF, Cole SR, Platt RW. Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology. 2009;20(4):488-495.
21. Jensen MK, Bertoia ML, Cahill LE, Agarwal I, Rimm EB, Mukamal KJ. Novel metabolic biomarkers of cardiovascular disease. Nat Rev Endocrinol. 2014;10(11):659-672.
22. HolmesMV,Dale CE, Zuccolo L, et al. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ. 2014;349:g4164.
23. Cook JR, Semple RK. Hypoadiponectinemia-cause or consequence of human "insulin resistance"? J Clin Endocrinol Metab. 2010;95(4):1544-1554.
24. Hamagami F, McArdle JJ. Advanced studies of individual differences linear dynamic models for longitudinal data analysis. In: New Developments and Techniques in Structural Equation Modeling. Mahwah, NJ: Lawrence Erlbaum Associates, Inc; 2001:203-246.
25. McArdle JJ, Hamagami F. Latent difference score structural models for linear dynamic analyses with incomplete longitudinal data. In: New Methods for the Analysis of Change. 1st ed. Washington, DC: American Psychological Association; 2001:137-176.
26. McArdle JJ, Grimm KJ. Five steps in latent curve and latent change score modeling with longitudinal data. In: Longitudinal Research with Latent Variables. Heidelberg, Berlin: Springer; 2010:245-273.
27. Muthén LK, Muthén BO. Mplus User's Guide. 7th ed. Los Angeles: Muthén, Muthén; 1998 (available at: http://www. statmodel. com).
28. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model. 1999;6(1):1-55.
29. Chikritzhs T, Stockwell T, Naimi T, Andreasson S, Dangardt F, Liang W. Hasthe leaningtowerofpresumedhealth benefitsfrom"moderate" alcohol use finally collapsed? Addiction. 2015;110(5):726-727.
30. Yaghootkar H, Lamina C, Scott RA, et al. Mendelian randomisation studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes. 2013;62(10):3589-3598.
31. Sook Lee E, Park S, Kim E, et al. Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int J Epidemiol. 2013;42(4):1029-1039.
32. Britton A,MarmotMG,Shipley MJ. Howdoes variability in alcohol consumption over time affect the relationship with mortality and coronary heart disease? Addiction. 2010;105(4):639-645.
33. Batty GD, Shipley M, Tabák A, et al. Generalizability of occupational cohort study findings. Epidemiology. 2014;25(6):932-933.
34. Conigrave KM, Hu BF, Camargo CA, Stampfer MJ, Willett WC, RimmEB. Aprospective study of drinking patterns in relation to risk of type 2 diabetes among men. Diabetes. 2001;50(10):2390-2395.
35. Fekjær HO. Alcohol-a universal preventive agent? A critical analysis. Addiction. 2013;108(12):2051-2057.
36. Mortensen EL, Jensen HH, Sanders SA, Reinisch JM. Better psychological functioning and higher social status may largely explain the apparent health benefits of wine: a study of wine and beer drinking in young Danish adults. Arch Intern Med. 2001;161(15):1844-1848.
37. Paschall MJ, Freisthler B, Lipton RI. Moderate alcohol use and depression in young adults: findings from a national longitudinal study. Am J Public Health. 2005;95(3):453-457.
38. Roerecke M, Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12(1):182.